Medical Device Business Investment Opportunities

- The first manufacturer of rapid tests. - Recognized brand in the market. - Our products were specially developed for lower-middle-income countries. - The manufacturing capacity is 3 million test kits per year. - We sell for pharmacies as well. - We have 4 permanent employees and hire contract-based employees when required.

- We manufacture different types of cryo chambers that are useful for chronic pain & inflammation, sports recovery, beauty and skin recovery, and rehabilitation. - Clients include Premier League football clubs in the UK, rugby clubs in France, ice hockey stadiums in the Czech Republic, and many more. - Production capacity is 10 machines a month. - We have multiple cryo chamber models for different requirements. - Have distributors in 40+ countries worldwide. 80% of our sales are through distributors. - Market value was USD 6.39 bn in 2021 and is growing at 7% per annum. - Company has a single owner and is debt free. - Owner is in the UK and looks after the business from there. - We have signed more contracts and won new orders which have increased our sales.

- The company manufactures equipment that is required in blood banks, hospitals and healthcare industries. - Company is registered as a startup in Startup India, is ISO13487:2016 and is WHO-GMP certified. - The main motive of the company is to provide products that are cost-effective and easily accessible. - Promoter has a master's degree from a reputed university and has more than 10 years of experience in this field. - Company's product line has more than 25 SKUs. - We are seeking INR 3 crores investment for the company's expansion. - Company has an INR 55 lakh OD limit with SBI. - There are 2 directors in the company with 51% and 49% shares. - Direct sales and marketing. sell equipment required for blood banks across India. - Sales have grown as we are working with more clients this year. * Other Highlights: - Bootstrapped med-tech company based out of Hyderabad. - We are OEM and have developed more than 25 products related to blood banks. - We are in process of developing advanced equipment, supporting the vision of the Make in India initiative. - Have distribution channels across the country. - Supplied our products to nearly 70 clients in India and other countries till date. - We offer AMC support to our clients. - The promoter has more than 10 years of experience in this industry. - Business owns the machinery, equipment, furniture, etc. - Trademark registration and filing of process patents are pending. - Planning to open a sales office in Dubai in the next 6 months.

- We design medical products based on the experience and needs felt by the patients and medical professionals. - Our vertigo (BPPV) treatment chair is substantially equivalent to legally marketed predicate devices and does not require approval of a pre-market approval application (PMA) according to FDA 510 (k) regulations. - We would like to use part of the investment to manufacture a model with a smaller footprint and better cosmetics. The models are ready. - USA is the market with the highest potential for our vertigo (BPPV) treatment device. - We have an AI-based decision support system (DSS) as an accessory to vertigo (BPPV) treatment chair to aid physicians to diagnose the condition. But the addition of the AI system may require PMA. - Company's main focus is on designing and production of ENT products. - We manufacture and design our products in-house and the manufacturing capacity is 2 devices per month but can scale up quickly to 20 and even higher if needed. - Promoters have put 3 years of research and development into the product designs. - We have just received our CE certifications to start commercial sales, so no revenue yet. - Products are tested and devices have been approved by Turkish Health Ministry authorities and are in the final stages of being offered for sale. - The success of our device is proven in the field by clinical trials. - The product has multiple national and international patent applications. - Our main product has received three awards, one of them by the votes of 75,000 medical professionals. - The product has been launched at two specialist medical congresses and has received approval from opinion leaders of the vestibular society. - Promoters have more than 30 years of experience in this field. - Company is debt-free and owned by 3 partners, two stakeholders have a 40% stake each and one minority stakeholder has a 20% stake in the company. - Vertigo (BPPV) is a notoriously difficult illness to treat. Statistically, patients visit the hospital 7 times on average and it takes 70 months to get a cure. - The misdiagnosis rate of BPPV in ER is as high as 80%. We have a robotic treatment system that simplifies diagnosis and treatment. - The average diagnosis and treatment time for 32 clinical trial patients was 20 minutes. We had patients who visited the hospital 14 times with no success yet were cured in 20 minutes. - BPPV affects 8% of the population but 1.6% of the whole population visits emergency rooms worldwide every year in every country for BPPV attacks.

- We have developed software especially for cognitive decline, rehabilitation treatment, we have developed some hardware for our software as well. - We are ISO-13485, ISO-9001, GMP certified and have won many awards, have many related patents. - Our clients are hospitals, clinics, medical centres, homes. - Have more than 20 clients at the moment. Some of the biggest hospitals in South Korea are our clients. - The global digital therapeutics market was valued at $3,537.29 million in 2020, and is projected to reach $23,569.38 million by 2030. - Recently started attending exhibitions and conferences which has increased our sales. - The CEO is a serial entrepreneur who has grown multiple businesses in the past. - Business has some loans taken from a bank and has 2 partners.

- The business was established in 2009 to promote the distribution of medical devices and medical supplies. - Many major North American and European manufacturers are represented by our company. - The company has progressed to acquire exclusive distribution agreements for all its major medical equipment, medical devices, and consumables providing unique solutions to the healthcare market in the Middle East. - The company gets its supplies from international brands like PerSys Medical, Hemostasis, Active Implants, etc. - The list of company clients has esteemed names like Dubai Health Authority, Hamad General Hospital, King's College Hospital London, etc. - The major revenue generation is through supplies to hospitals and distributors in Dubai. - The sales are increasing after the Covid 2020 situation.

- Business is in the manufacturing industry. - We manufacture aqua-based medical therapy equipment. - The equipment that we manufacture are water treadmills, health pools and many more. - These products are for physiotherapy of the pediatric population. - We cater to B2B clients. - Business has served 13 clients. - We currently have 4 client orders on which we are working at the moment. - We take 45 days to complete our order. - Our sales dropped last year due to the pandemic.

- We are a manufacturing, distribution, and software development company for healthcare devices powered by AI. - This company is a holding company and controlling all groups of companies in various countries. - We have a staff strength of 21, predominantly in engineering and software development. - A clinical trial for utilizing our ovulation tracker instead of conventional tests has been signed, as has a clinical trial for using our basal body temperature patch to assist pregnant women in monitoring the level of corpus lutetium to prevent miscarriages. - We received orders from retirement villages, hospitals, and home care units in China for the supply of our temperature patch. - We have a distribution channel for our product in four pharmacy chains, with a total of 600 stores. - Currently, there are 10 products that are in pipeline and are to be launched soon. - As this is a holding company and other manufacturing companies are its subsidiaries. So through those companies manufacturing and distributing the revenue is generated for the business.